Dyk ned i forskningsemnerne om 'TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients'. Sammen danner de et unikt fingeraftryk.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science